Papers

2

Total Citations

3

H-Index

1

About

Shu-Shong Hsu is a pathologist and researcher specializing in the diagnosis and classification of rare renal tumors, with a particular focus on mucinous tubular and spindle cell carcinoma (MTSCC). His work has contributed to the clinical understanding of this uncommon renal cell carcinoma subtype, which was formally recognized as an independent entity in the latest World Health Organization (WHO) classification. Through detailed case reports and literature reviews, Hsu has helped characterize the clinical presentation, histopathological features, and diagnostic challenges of MTSCC, as illustrated by his report of a 51-year-old female patient who presented with abdominal pain. His publications, while recent, serve as valuable references for pathologists and urologists encountering these rare neoplasms in practice. By documenting and analyzing such cases, Hsu supports the broader effort to refine diagnostic criteria and improve patient management for rare kidney cancers. His work underscores the importance of case-based research in advancing the classification and treatment of uncommon malignancies.

Research Focus

Key Achievements

1
H-Index
2
Papers
3
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Mucinous Tubular and Spindle Cell Carcinoma: Case Report and Literature Review
2 citations · 2025
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Queen Mary Hospital, University of Hong Kong

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 0 days ago